Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office
2008
Alcaligenes xylosoxidans Infections in Cancer Patients
publication
Author Information
Author(s): Moon Kim, MD, MPH, Elizabeth Bancroft, MD, SM, Eleanor Lehnkering, MS, Rodney M. Donlan, PhD, Laureen Mascola, MD, MPH, Charles P. Vega, MD
Primary Institution: University of California, Irvine
Conclusion
The study identifies risk factors and clinical presentations associated with Alcaligenes xylosoxidans infections in outpatient oncology settings.
Supporting Evidence
- A. xylosoxidans is associated with healthcare-associated infections.
- Patients with A. xylosoxidans infection had symptoms attributed to chemotherapy side effects.
- Case-patients with A. xylosoxidans infection were more likely to have a central venous catheter.
Takeaway
This study helps doctors understand how a specific germ can make cancer patients sick and what to look for.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website